Browsing: Delays

Cell therapies are growing in variety and effectiveness across many diseases. In the fight against Duchenne muscular dystrophy (DMD), deramiocel has emerged as an effective treatment for DMD in patients in early clinical trials. New data from the HOPE-3 Phase III clinical trial, published inThe Lancet, expand the efficacy to include patients with advanced DMD